ShannonLeigh(Huggins)Huggins-PuhallaMD

Oncology • Pittsburgh, PA

Breast Cancer, Hematologic Oncology

Physician

Join to view full profile

Dr. Huggins-Puhalla is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Huggins-Puhalla's full profile

Already have an account?

Office
300 Halket St
Pittsburgh, PA 15213
Phone+1 412-641-4530

Education & Training

Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2004 - 2007
Ohio State University HospitalResidency, Internal Medicine, 2001 - 2004
Northeast Ohio Medical UniversityClass of 2001

Certifications & Licensure

PA State Medical License 2007 - 2024
OH State Medical License 2001 - 2008
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

27 citations
Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo...
Eve Rodler, Priyanka Sharma, William E Barlow, Julie R Gralow, Shannon L Puhalla
The Lancet. Oncology. 2023-02-01
56 citations
Atezolizumab With Neoadjuvant Anti-Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Early Breast ...
Jens Huober, Carlos H Barrios, Naoki Niikura, Michał Jarząb, Yuan-Ching Chang
Journal of Clinical Oncology. 2022-09-01
6 citations
A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovari...
Julia Manzo, Shannon Puhalla, Shalu Pahuja, Fei Ding, Yan Lin
Cancer Chemotherapy and Pharmacology. 2022-05-01